{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:06Z","timestamp":1792788486049,"version":"4.5.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CRC\/Transregio","award":["205\/2"],"award-info":[{"award-number":["205\/2"]}]},{"name":"CRC\/Transregio","award":["314061271"],"award-info":[{"award-number":["314061271"]}]},{"name":"CRC\/Transregio","award":["TRR 205"],"award-info":[{"award-number":["TRR 205"]}]},{"name":"CRC\/Transregio","award":["\u201cYoung Talents in Clinical Research\u201d"],"award-info":[{"award-number":["\u201cYoung Talents in Clinical Research\u201d"]}]},{"name":"G. & J. Bangerter-Rhyner Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Pheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors that frequently produce catecholamines. Catecholamine-induced cardiometabolic complications substantially contribute to increased morbidity and mortality in PPGL patients prior to surgical resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether markers of elevated cardiometabolic risk persist in patients following PPGL resection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective analysis of a multicenter cohort of patients with PPGLs participating in the prospective ProsPheo study and the ENS@T registry, cardiometabolic risk factors, including glycemic status, dyslipidemia, and body mass index (BMI), were assessed in patients with PPGL at diagnosis and during follow-up. Patients with a history of resected PPGL were compared to a control group with nonfunctioning adrenal adenomas from the ENS@T registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with a present PPGL or a history of PPGL (n = 188), a metastatic PPGL (n = 27), or a known susceptibility gene pathogenic variant (PV) for the development of PPGL without a history of PPGL (n = 44) were included. We compared the asymptomatic PV carriers to patients with a history of PPGL: those with a history of PPGL showed a significantly higher prevalence of hyperglycemic disorders (P = .013) compared with asymptomatic PV carriers. In patients with a history of PPGL and at least 12 months of follow-up post surgery (n = 113), the prevalence of hyperglycemic disorders (P &amp;lt; .001), as well as the mean HbA1c (5.63%, SD 0.43%), were significantly higher, compared to a control group with nonfunctioning adrenal adenomas (n = 76) of similar age and BMI (HbA1c 5.45%, SD 0.40%; P = .004).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glycemic disturbances persist long-term after the resection of PPGL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae901","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:24:37Z","timestamp":1735572277000},"page":"e2966-e2976","source":"Crossref","is-referenced-by-count":10,"title":["Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma\/Paraganglioma"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4555-8334","authenticated-orcid":false,"given":"Alessa","family":"Fischer","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH) , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-5910","authenticated-orcid":false,"given":"Hanna","family":"Remde","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-1604","authenticated-orcid":false,"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Dischinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of W\u00fcrzburg , W\u00fcrzburg 97080 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-333X","authenticated-orcid":false,"given":"Nicole","family":"Bechmann","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-5902","authenticated-orcid":false,"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO) , Madrid 28029 ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras , Madrid 28029 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7795-1395","authenticated-orcid":false,"given":"Katharina","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vetter","sequence":"additional","affiliation":[{"name":"Department of Visceral and Transplantation Surgery, University Hospital , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Oberholzer","sequence":"additional","affiliation":[{"name":"Department of Visceral and Transplantation Surgery, University Hospital , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-6772","authenticated-orcid":false,"given":"Gr\u00e9goire B","family":"Morand","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Andreas","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9639-3213","authenticated-orcid":false,"given":"Ralph","family":"Fritsch","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Gruber","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH) , Zurich 8091 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8906-2563","authenticated-orcid":false,"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH) , Zurich 8091 ,","place":["Switzerland"]},{"name":"Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2341-3161","authenticated-orcid":false,"given":"Kathrin","family":"Zitzmann","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-3722","authenticated-orcid":false,"given":"Christoph J","family":"Auernhammer","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3767","authenticated-orcid":false,"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[{"name":"AKESO , Prague 5 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-6186","authenticated-orcid":false,"given":"Ashley B","family":"Grossman","sequence":"additional","affiliation":[{"name":"Green Templeton College, University of Oxford , Oxford OX2 6HG ,","place":["UK"]},{"name":"NET Unit, ENETS Centre of Excellence, Royal Free Hospital , London NW3 2QG ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3984","authenticated-orcid":false,"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH) , Zurich 8091 ,","place":["Switzerland"]},{"name":"Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich , Munich 80336 ,","place":["Germany"]},{"name":"The LOOP Zurich Medical Research Center , Zurich 8044 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7064-590X","authenticated-orcid":false,"given":"Svenja","family":"N\u00f6lting","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), University of Zurich (UZH) , Zurich 8091 ,","place":["Switzerland"]},{"name":"Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"2","key":"2025081215531822400_dgae901-B1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2025081215531822400_dgae901-B2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"2","key":"2025081215531822400_dgae901-B3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2025081215531822400_dgae901-B4","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/s41467-022-34011-3","article-title":"Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment","volume":"13","author":"Zethoven","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"2025081215531822400_dgae901-B5","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/clinem\/dgaa502","article-title":"Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma","volume":"105","author":"Jiang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025081215531822400_dgae901-B6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"2025081215531822400_dgae901-B7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: a multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025081215531822400_dgae901-B8","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-prono study): a European network for the study of adrenal tumors retrospective study","volume":"104","author":"Hescot","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025081215531822400_dgae901-B9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"issue":"8","key":"2025081215531822400_dgae901-B10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"2025081215531822400_dgae901-B11","doi-asserted-by":"crossref","first-page":"1021420","DOI":"10.3389\/fendo.2022.1021420","article-title":"Silent pheochromocytoma and paraganglioma: systematic review and proposed definitions for standardized terminology","volume":"13","author":"Constantinescu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"2025081215531822400_dgae901-B12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","author":"Eisenhofer","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"2025081215531822400_dgae901-B13","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the Succinate Dehydrogenase Subunit B gene","volume":"93","author":"Timmers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025081215531822400_dgae901-B14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1373\/clinchem.2004.045484","article-title":"Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines","volume":"51","author":"Eisenhofer","year":"2005","journal-title":"Clin Chem"},{"issue":"4","key":"2025081215531822400_dgae901-B15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von hippel\u2013lindau syndrome","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2025081215531822400_dgae901-B16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025081215531822400_dgae901-B17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-19-0159","article-title":"Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion","volume":"181","author":"Geroula","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025081215531822400_dgae901-B18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The north American neuroendocrine tumor society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"12","key":"2025081215531822400_dgae901-B19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1530\/EC-21-0462","article-title":"Effect of adrenalectomy on remission of subclinical left ventricular dysfunction in patients with pheochromocytoma: a speckle-tracking echocardiography study","volume":"10","author":"Kvasni\u010dka","year":"2021","journal-title":"Endocr Connect"},{"issue":"Suppl 3","key":"2025081215531822400_dgae901-B20","doi-asserted-by":"crossref","first-page":"A70.1","DOI":"10.1136\/heartjnl-2014-306118.122","article-title":"122 cardiac abnormalities are common in patients diagnosed with phaeochromocytoma as detected by cardiovascular magnetic resonance imaging","volume":"100","author":"Ferreira","year":"2014","journal-title":"Heart"},{"issue":"9","key":"2025081215531822400_dgae901-B21","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2017-00357","article-title":"Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma","volume":"102","author":"Komada","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2\/3","key":"2025081215531822400_dgae901-B22","first-page":"129","article-title":"Metabolic alterations in patients with pheochromocytoma","volume":"127","author":"Erlic","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2025081215531822400_dgae901-B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","article-title":"Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study","volume":"81","author":"Elenkova","year":"2020","journal-title":"Ann Endocrinol"},{"issue":"10","key":"2025081215531822400_dgae901-B24","doi-asserted-by":"crossref","first-page":"e4028","DOI":"10.1210\/clinem\/dgab401","article-title":"Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma","volume":"106","author":"Krumeich","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025081215531822400_dgae901-B25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1210\/jc.2012-3625","article-title":"Changes in energy metabolism in pheochromocytoma","volume":"98","author":"Petr\u00e1k","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025081215531822400_dgae901-B26","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jc.2003-030000","article-title":"Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma","volume":"88","author":"Wiesner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025081215531822400_dgae901-B27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/cen.12536","article-title":"Hypertension and hypertensive cardiomyopathy in patients with a relapse-free history of phaeochromocytoma","volume":"82","author":"Weismann","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Supplement_1","key":"2025081215531822400_dgae901-B28","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. diagnosis and classification of diabetes: standards of Care in Diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"3","key":"2025081215531822400_dgae901-B29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MED.0000000000000634","article-title":"Genetics of pheochromocytoma and paraganglioma","volume":"28","author":"Wachtel","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"2025081215531822400_dgae901-B30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"key":"2025081215531822400_dgae901-B31","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024"},{"issue":"6","key":"2025081215531822400_dgae901-B32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/EJE-19-0589","article-title":"Metabolic impact of pheochromocytoma\/paraganglioma: targeted metabolomics in patients before and after tumor removal","volume":"181","author":"Erlic","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025081215531822400_dgae901-B33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40618-021-01715-0","article-title":"Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case\u2013control study","volume":"45","author":"Feola","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"2025081215531822400_dgae901-B34","first-page":"100322","article-title":"Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): further insights into an under recognized entity","volume":"33","author":"Osher","year":"2023","journal-title":"J Clin Transl Endocrinol"},{"issue":"10","key":"2025081215531822400_dgae901-B35","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/cancers11101505","article-title":"Current management of pheochromocytoma\/paraganglioma: a guide for the practicing clinician in the era of precision medicine","volume":"11","author":"N\u00f6lting","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2025081215531822400_dgae901-B36","first-page":"511","article-title":"Diabetes mellitus in phaeochromocytoma fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma","volume":"106","author":"Stenstr\u00f6m","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"2025081215531822400_dgae901-B37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-51-4-930","article-title":"Hormonal and metabolic studies in a patient with a pheochromocytoma","volume":"51","author":"Turnbull","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025081215531822400_dgae901-B38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","article-title":"Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis","volume":"12","author":"Reith","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025081215531822400_dgae901-B39","doi-asserted-by":"crossref","first-page":"100121","DOI":"10.1016\/j.deman.2022.100121","article-title":"Prevalence and risk factors associated with prediabetes and undiagnosed diabetes in France: the national CONSTANCES cohort","volume":"10","author":"Lailler","year":"2023","journal-title":"Diabetes Epidemiol Manag"},{"issue":"2","key":"2025081215531822400_dgae901-B40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"issue":"7466","key":"2025081215531822400_dgae901-B41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(66)92986-2","article-title":"INHIBITION OF INSULIN SECRETION BY A PH\u00c6OCHROMOCYTOMA","volume":"288","author":"Wilber","year":"1966","journal-title":"The Lancet"},{"issue":"6","key":"2025081215531822400_dgae901-B42","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1210\/clinem\/dgaa154","article-title":"Pheochromocytoma with adrenergic biochemical phenotype shows decreased GLP-1 secretion and impaired glucose tolerance","volume":"105","author":"Petr\u00e1k","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025081215531822400_dgae901-B43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1172\/JCI109718","article-title":"Epinephrine-induced insulin resistance in man","volume":"65","author":"Deibert","year":"1980","journal-title":"J Clin Invest"},{"issue":"12","key":"2025081215531822400_dgae901-B44","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1172\/JCI104443","article-title":"The role of plasma free fatty acids in development of fatty liver","volume":"40","author":"Feigelson","year":"1961","journal-title":"J Clin Invest"},{"issue":"2","key":"2025081215531822400_dgae901-B45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0006-291X(03)01360-3","article-title":"Norepinephrine induces hepatic fibrogenesis in leptin deficient ob\/ob mice","volume":"308","author":"Oben","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2025081215531822400_dgae901-B46","doi-asserted-by":"crossref","first-page":"G877","DOI":"10.1152\/ajpgi.00537.2005","article-title":"Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells","volume":"291","author":"Sancho-Bru","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"2025081215531822400_dgae901-B47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2265.1991.tb00284.x","article-title":"Metabolic effects of pharmacological adrenergic blockade in phaeochromocytoma","volume":"34","author":"Krentz","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025081215531822400_dgae901-B48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00268-019-05175-9","article-title":"Surgical resection of pheochromocytomas and paragangliomas is associated with lower cholesterol levels","volume":"44","author":"Good","year":"2020","journal-title":"World J Surg"},{"issue":"8","key":"2025081215531822400_dgae901-B49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae901\/61318611\/dgae901.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e2966\/61318611\/dgae901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e2966\/61318611\/dgae901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:53:34Z","timestamp":1755028414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/9\/e2966\/7941442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,1,2]]},"published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae901","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,1,2]]}}}